Dr Reddy Laboratories : Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Form 6-K
Disclosure under Regulation 30 of the SEBI Regulations, 2015 The Board of Directors of the Company at its meeting held on May 10, 2023, has inter alia approved the following: ... | May 10, 2023
United States Peter Prock Claudio Albrecht Biosimilar Filgrastim Ratiopharm Biosimilars Ratiopharm Group
Source: marketscreener.com